Impact of different methods for describing the extent of prior antibiotic exposure on the association between antibiotic use and antibiotic-resistant infection

被引:31
作者
Hyle, Emily P.
Bilker, Warren B.
Gasink, Leanne B.
Lautenbach, Ebbing
机构
[1] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Ctr Res & Educ Therapeut, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
关键词
D O I
10.1086/516798
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective. Many studies have investigated the association between prior antibiotic use and antibiotic resistance. However, methods used in past studies to describe the extent of prior antibiotic use (eg, use of the 2 categories exposure versus no exposure and measurement of duration of exposure) have not been reviewed. The impact of the use of different methods for quantifying the use of antibiotics is unknown. The objectives of this study were to characterize past approaches to describing the extent of antibiotic use and to identify the impact of the use of different methods on associations between use of specific antibiotics and infection with an antibiotic-resistant-organism. Methods. We conducted a systematic review of studies that investigated risk factors for extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella species to identify variability in past approaches to describing the extent of antibiotic use. We then reanalyzed a data set from a prior study of risk factors for infection with ESBL-producing E. coli and Klebsiella species. We developed 2 separate multivariable models: 1 in which prior antibiotic use was described as a categorical variable (eg, exposure or no exposure) and 1 in which antibiotic use was described as a continuous variable (eg, measured in antibiotic-days). These models were compared qualitatively. Setting. Large academic medical center. Results. The 25 articles included in the systematic review revealed a variety of methods used to describe the extent of prior antibiotic exposure. Only 1 study justified its approach. Results from the 2 multivariable models that used different methodologic approaches differed substantially. Specifically, use of third-generation cephalosporins was a risk factor for infection with ESBL-producing E. coli and Klebsiella species when antibiotic use was described as a continuous variable but not when antibiotic use was described as a categorical variable. Conclusions. There has been no consistent method for assessing the extent of prior antibiotic exposure. The use of different methods may substantially alter the identified antimicrobial risk factors, which has important implications for the resultant interventions regarding antimicrobial use.
引用
收藏
页码:647 / 654
页数:8
相关论文
共 37 条
[1]  
AGATA EM, 2006, INFECT CONT HOSP EP, V27, P670
[2]   Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species:: Risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence [J].
Bisson, G ;
Fishman, NO ;
Patel, JB ;
Edelstein, PH ;
Lautenbach, E .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2002, 23 (05) :254-260
[3]   Extended-spectrum β-lactamases in the 21st century:: Characterization, epidemiology, and detection of this important resistance threat [J].
Bradford, PA .
CLINICAL MICROBIOLOGY REVIEWS, 2001, 14 (04) :933-951
[4]   Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients [J].
Colodner, R ;
Rock, W ;
Chazan, B ;
Keller, N ;
Guy, N ;
Sakran, W ;
Raz, R .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2004, 23 (03) :163-167
[5]   A CASE-CONTROL STUDY OF AN OUTBREAK OF INFECTIONS CAUSED BY KLEBSIELLA-PNEUMONIAE STRAINS PRODUCING CTX-1 (TEM-3) BETA-LACTAMASE [J].
DECHAMPS, C ;
ROUBY, D ;
GUELON, D ;
SIROT, J ;
SIROT, D ;
BEYTOUT, D ;
GOURGAND, JM .
JOURNAL OF HOSPITAL INFECTION, 1991, 18 (01) :5-13
[6]   Risk factors for antibiotic-resistant Escherichia coli isolated from community-acquired urinary tract infections in Dakar, Senegal [J].
Dromigny, JA ;
Nabeth, P ;
Juergens-Behr, A ;
Perrier-Gros-Claude, JD .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (01) :236-239
[7]   Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection:: risk factors and clinical outcome [J].
Du, B ;
Long, Y ;
Liu, HZ ;
Chen, DC ;
Liu, DW ;
Xu, YC ;
Xie, XL .
INTENSIVE CARE MEDICINE, 2002, 28 (12) :1718-1723
[8]   High-dose, short-course Levofloxacin for community-acquired pneumonia: A new treatment paradigm [J].
Dunbar, LM ;
Wunderink, RG ;
Habib, MP ;
Smith, LG ;
Tennenberg, AM ;
Khashab, MM ;
Wiesinger, BA ;
Xiang, JX ;
Zadeikis, N ;
Kahn, JB .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (06) :752-760
[9]   Antimicrobial resistance determinants and future control [J].
Harbarth, S ;
Samore, MH .
EMERGING INFECTIOUS DISEASES, 2005, 11 (06) :794-801
[10]   Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: A systematic review [J].
Harris, AD ;
Karchmer, TB ;
Carmeli, Y ;
Samore, MH .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (07) :1055-1061